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Mod5 is a multifunctional protein that modifies a subset of tRNAs in the
cytoplasm and is also required for an RNA-mediated form of transcriptional
silencing. Previous in vivo studies have shown that the nuclear silencing func-
tion of Mod5 does not require that the causative tRNA gene encode a Mod5
substrate, although Mod5 is still required. However, previous data have not
directly tested whether Mod5 can directly bind substrate and nonsubstrate
RNAs. We herein demonstrate that Mod5 directly binds to both substrate
and nonsubstrate RNAs, including a highly structured, non-tRNA sequence
(5S-rRNA), consistent with previous in vivo data. Furthermore, we show that
some RNAs drastically change the aggregation behavior of Mod5 with impli-
cations for tRNA gene-mediated silencing.
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tRNA isopentenyl transferases are highly conserved
enzymes that transfer an isopentenyl group from
dimethylallylpyrophosphate (DMAPP) to the N6 posi-
tion of A37, adjacent to the anticodon [1–9].The Sac-
charomyces cerevisiae enzyme, Mod5, resides primarily
in the cytoplasm where it modifies mitochondrial and
cytoplasmic tRNAs [10–12]. Mod5 modifies a subset
of tRNAs with specific sequence requirements (AAA)
surrounding the target nucleotide at A37 [13,14]. Sub-
strates in yeast and humans [15] include Tyr, Ser,
Trp, and Cys-isoacceptor tRNAs. This modification
on a tRNA increases tRNA stability [16] and the fide-
lity and efficiency of translation—an effect related to
the tRNA’s affinity for the ribosome [2,5,17,18].
A small fraction of the enzyme also resides in the
nucleus [19,20], where it is required for a form of
Abbreviations
DMAPP, dimethylallylpyrophosphate; EM, electron microscopy; GMSA, gel mobility shift assay; RSC, remodel the structure of chromatin;
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transcriptional silencing, termed tRNA gene-mediated
(tgm) silencing [11,21–23]. tgm silencing was originally
observed in budding yeast as antagonizing pol II gene
promoters adjacent to tRNA genes [24]. The silencing
does not involve steric interference, was shown to occur
upstream or downstream of the tRNA gene [24], and is
dependent on histone modifications and chromatin
remodeling [25]. This phenomenon also requires the
clustering of the tRNA genes to the nucleolus, demon-
strating a role for nuclear architecture and localization
[23,26,27]. Deletion of the MOD5 gene relieves silencing
of a pol II promoter adjacent to a tRNA gene on a
reporter plasmid [21,23]. Recently, a form of tgm silenc-
ing has been proposed to exist in human cells [28].
Mod5 involvement in tgm silencing mechanisms
was further confirmed by the following observations
[22]: (a) Mod5 protein is physically associated with
tRNA gene loci, (b) Mod physically associates with
pol III transcription complex proteins, (c) Mod5 cop-
urifies with multiple proteins of a remodel the struc-
ture of chromatin (RSC) and histones that affect tgm
silencing, and (d) Mod5 coimmunoprecipitates with
precursor-tRNAs (pretRNA) that are thought to be
found exclusively in the nucleus. Interestingly, Mod5
was found to coimmunoprecipitate with both sub-
strate and nonsubstrate tRNAs for isopentenylation,
but preferentially with corresponding nuclear pre-
tRNAs in both types of RNA. This was consistent
with the observation that tRNA genes encoding sub-
strate or nonsubstrate pre-tRNAs are both capable of
conferring tgm silencing [22], suggesting that the
specificity of Mod5 for enzymatic modification of
tRNA in the cytoplasm is distinct from that of its
nuclear role in transcriptional silencing. Lastly, trun-
cation of the pre-tRNA transcripts by early termi-
nation compromised tgm silencing, suggesting the
mechanism required a tRNA-like transcript for
efficiency.
Based on these data, we hypothesize that complexes
between Mod5 and nascent pretRNAs at the site of
transcription might recruit chromatin modification and
remodeling proteins that affect local chromatin struc-
ture to impart silencing of nearby transcription by
RNA polymerase II. This mechanism would require
that Mod5 binds pretRNAs whether or not they are
substrates for modification at A37, which has not pre-
viously been shown. Testing this was complicated by
the prion-like tendency of Mod5 to aggregate in solu-
tion and in vivo, in agreement with recent studies
showing that Mod5 forms heritable amyloid-like
aggregates [29]. It is possible to select for this heritable
aggregation in vivo by growth in certain fungicides that
require loss of Mod5 modifications of tRNAs (e.g.,
fluconazole). However, this aggregation of Mod5
affects only cytoplasmic tRNA modification and not
the nuclear silencing function [11,22].
In this study, we show for the first time that Mod5
directly binds to both substrate and nonsubstrate
RNAs in vitro, as well as the corresponding primary
transcript pre-tRNAs. Further, binding to tRNA-like
molecules facilitates aggregation of Mod5. We propose
a model for tgm silencing that includes binding of pre-
tRNAs by Mod5.
Materials and methods
Recombinant Mod5 expression and purification
The endogenous Mod5 ORF was amplified by PCR from a
genomic DNA preparation of yeast BY4741 cells using pri-
mers with Nde1 and Xho1 sequences. PCR products were
digested with Nde1 and Xho1 and ligated into the pet15B
vector, a bacterial expression plasmid with a 69 histidine
Cterminal tag. The plasmid was transformed into BL21
Escherichia coli by electroporation using a Bio-Rad (Bio-
Rad Laboratories, Inc., Hercules, CA, USA) Gene Pulser
at 2.5 kV, 25 lF, 200 Ohms (http://springerlab.tch.harva
rd.edu/springer/uploads/Equipment/Genepulsermanual.pdf
). Eight liters of E. coli was grown to OD (600 nm) 0.55 in
LB + 100 lgmL1 ampicillin (37 °C) and then induced
with 1.5 mM IPTG (5 h, 17 °C). Cells were pelleted at 2620
RCF, 15 min, 4 °C, and frozen at 80 °C. Pellets were
resuspended in 120 mL buffer (50 mM Tris/HCl, 50 mM
NaCl, pH 7.5) on ice. Cells were lysed using a Divitech
Microfluidizer (model 110Y) using two passes with 200-lm
orifice cartridge and then 8 passes with 100-lm cartridge.
Lysate was centrifuged at 5470 RCF, 15 min, 4 °C, and the
supernatant combined with 60-mL packed, pre-equilibrated
BioRex 70 (Bio-Rad Laboratories, Inc.) cation exchange
resin (50 mM Tris/HCL, 50 mM NaCl, pH 7.5). The lysate
was allowed to bind for 1 h (4 °C) and spun for 5 min at
152 RCF, and the supernatant was discarded. Resin was
washed twice with one volume buffer (200 mM NaCl,
50 mM Tris/HCl, pH 7.5). Protein was eluted with two
resuspensions using 500 mM NaCl, 50 mM Tris/HCl, pH
7.5 using one packed resin volume. Elutions were loaded
onto a 5 mL packed column of TALON nickel affinity
resin at 4 °C. The column was washed with 50 mL buffer
(300 mM NaCl, 20 mM NaPO4, pH 7.0) and eluted with
5.5 mL 450 mM imidazole, 50 mM NaPO4, 300 mM NaCl,
pH 8.0. Eluent was run on an 80 mL Sephacryl S-100 col-
umn (2.7 cm diameter 9 19.1 cm height) using 50 mM Tris/
HCl, 50 mM NaCl, pH 7.5 buffer at a rate of 1 mL flow-
through per minute at 4 °C. Seven hundred and fifty micro-
liter fractions were collected, examined by SDS/PAGE, and
then the 10 highest concentration fractions were combined,
aliquoted, and stored at 80 °C.
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DNA template synthesis
Template DNA fragments for transcription (Fig. S2) were
ordered through Integrated DNA Technologies. Lyophi-
lized DNA pellets were dissolved in 10 mM Tris/HCl con-
taining 1 mM EDTA, to a concentration of 100 lM. Equal
volumes of overlapping, complementary strand pairs were
combined and hybridized at 37 °C overnight. Ten micro-
liters of the 50 lM solutions of hybridized DNA was then
added to a solution with a final concentration of 0.4 lM
DNTPs, 10 mM Tris/HCl, pH 7.4, 50 mM KCl, 1.5 mM
MgCl2, and up to 5 units Taq DNA polymerase [30] in a
final volume of 50 lL. The solutions were then incubated
at 35 °C for 5 min, 45 °C for 5 min, 55 °C for 5 min,
65 °C for 30 min, and 37 °C for 15 min, ethanol-precipi-
tated, resuspended in 15 lL of water, and stored at
20 °C.
In vitro transcription and RNA purification
For each transcription reaction, 200 lL solutions of
50 mM Tris/HCl pH 7.5, 15 mM MgCl2, 5 mM DTT,
2 mM spermidine, 2 mM ATP, UTP, GTP, CTP, 2/25 of
volume template (see above), and empirically titrated
His6tagged T7 RNA polymerase [31] were incubated
12 h at 42 °C. Solutions were centrifuged at 15 400 RCF
for 5 min to remove pyrophosphate precipitate, and the
supernatants were ethanol-precipitated, gelpurified
through a 12% polyacrylamide gel, visualized by shadow-
ing with long-wave UV light, and passively eluted out of
gel slices. RNA was ethanol-precipitated, resuspended in
19 TE (10 mM Tris/HCl pH 7.5, 0.1 mM EDTA), and
stored at 80 °C. Radioactive transcripts were prepared
as above, except 0.5 mM ATP containing 10 lCi radioac-
tive aATP (PerkinElmer, Waltham, MA, USA) was
substituted in the above reaction and MgCl2 was reduced
to 12 mM.
End-labeling of 5S-rRNA
5S-rRNA was prepared as described above. RNA was
incubated with calf intestinal alkaline phosphatase (New
England Biolabs, Ipswich, MA, USA; 20 lL reaction, 1
unit CIP, 17 pmol 5S-rRNA, 19 final (New England
Biolabs) cutSmart buffer) for 30 min at 37 °C. RNA was
diluted to 50 lL using H2O, then extracted twice, first
with 50 lL of 25 : 24 : 1 phenol : chloroform : isoamyl
alcohol, and then once with 50 lL of chloroform. RNA
was ethanol-precipitated and then resuspended for
radioactive end-labeling (50 lL volume, 19 (New Eng-
land Biolabs) polynucleotide kinase buffer, 20 units PNK
(New England Biolabs), 10 lCi radioactive gamma
32PATP). The reaction was incubated for 30 min at
37 °C, extracted and ethanol-precipitated, and then resus-
pended in 50 lL of 200 mM NaCl.
Gel mobility shift assays
Sixteen micromolar Mod5 was serially diluted threefold into
buffer (50 mM Tris/HCl pH 7.2, 50 mM NaCl), in 10 lL ali-
quots. Next, for all tRNA, 5 lL of 32Plabeled RNA
(~ 100 CPMlL1) diluted in 39 binding buffer (24 mM
Tris/HCl pH 7.2, 150 mM NaCl, 15 mM MgCl2) was added
to each tube and incubated at 37 °C for 30 min. For the 5S
binding, ~ 36 000 CPMlL1 was used, approximately a six-
fold higher RNA concentration than for tRNA binding.
After incubation, 3 lL of 69 loading buffer (60% glycerol,
0.1% xylene cyanol) was added and 10 lL was run on an
8% native polyacrylamide gel in TBE buffer at 30 mA
(1 mm thick gel, 7 cm length, Aquebogue Machine Shop
Model 200). Gels were dried overnight, exposed on Phospho-
rimager screens overnight, and imaged on a Typhoon 9210
Imager (GE Healthcare, Chicago, IL, USA). Band intensities
were analyzed using ImageQuant software, and statistical
analysis was performed with GRAPHPAD Prism (GraphPad
Software, Inc., La Jolla, CA, USA).
RNA competition assays
Ten micromolar of 20 lM unlabeled competitor RNAs was
titrated using twofold serial dilutions in 19 TE (10 mM
Tris/HCl pH 7.5, 0.1 mM EDTA) to a final volume of 5 lL
each. Five microliters of 32P-labeled preTyr RNA
(~ 100 CPMlL1) diluted in 39 binding buffer (24 mM
Tris/HCl pH 7.2, 150 mM NaCl, 15 mM MgCl2) was added
to unlabeled competitor RNA tubes. Five microliters of
16 lM purified Mod5 was added to the above mixture for a
final Mod5 concentration of 5.3 lM, 15 lL final reaction
volume. Samples were incubated at 37 °C for 30 min; then,
3 lL of 69 loading buffer (60% glycerol, 0.1% xylene cya-
nol) was added, and samples were run on an 8% native
polyacrylamide gel in TBE buffer at low power (30 mA,
1 mm thick gel, 7 cm length, Aquebogue Machine Shop
Model 200). Gels were analyzed as above. IC50 values and
confidence intervals were calculated using GRAPHPAD Prism.
Data were fit to
y ¼ Bottomþ ðTop –BottomÞ
1þ 10ðxLog10ðIC50ÞÞ
‘Top’ was given a constraint of ≤ 100% bound, while
‘Bottom’ was constrained to ≥ 0%.
Isopentenylation assay
Reactions were performed in 58 mM Tris/HCl pH 7.2,
1.2 mM ATP, 5.8 mM MgCl2,  0.2 mM DMAPP, 10 U
SuperRNaseIn (Thermo Fisher Scientific, Waltham, MA,
USA), 40 000 CPM of internally 32Plabeled RNA, 5.3 lM
Mod5, 1.2 mM b-mercaptoethanol in a 17 lL final reaction
volume. Reactions were incubated at 37 °C for 1 h, and
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RNAs were ethanol-precipitated. RNA pellets were washed
one time with 70% ethanol, air-dried, and resuspended in
10 lL of 8 M urea, and 150 U of RNase T1 (Roche) was
added to each. Samples were incubated overnight at 37 °C.
Next, 2 lL of 69 loading buffer (60% glycerol, 0.1%
xylene cyanol) was added to each and 10 lL was loaded
onto a 20% polyacrylamide, 7 M urea denaturing gel (pre-
run at 20 mA, for 2 h, 1 mm thick gel, 70 cm length,
Aquebogue Machine Shop Model 200). Samples were run
at 25 mA, 1 mm thick gel, 7 cm length, Aquebogue
Machine Shop Model 200, 2 h. The gel was exposed on a
phosphorscreen for 3 h and imaged on Typhoon 9210 (GE
Healthcare).
Light scattering assay
Samples (7.5 lM Mod5,  7.5 lM RNA, in 125 mM NaCl,
5 mM potassium phosphate, 12.5 mM Tris/HCl, pH 7.4),
100 lL final volume, were loaded into a 96well Costar
plate. A405 was recorded using a Tecan Safire II at 37 °C.
Readings were performed in duplicate and normalized to
buffer-only A405.
Fluorescent microscopy
Imaging used an Olympus IX70 inverted microscope with a
CoolSNAP HQ2 monochrome camera, 1009 oil immersion
lens. Mod5 was incubated with a fluorescein-conjugated
RNA samples (1 lM FlpreSer-tRNA, 7.5 lM Mod5,
125 mM NaCl, 5 mM potassium phosphate, 12.5 mM Tris/
HCl, pH 7.4, 20 lL volume) for 1.5 h in humid conditions
at 37 °C on No. 1.5 glass coverslips. Imaging used 492 nm
excitation, 535 nm emission.
Electron microscopy
Eighteen micromolar Mod5,  7.5 lM pLeu/mLeu/pTyr/
mTyr/5S-rRNA, 75 mM NaCl, 3 mM NaPO4, 7.5 mM Tris/
HCl (pH 7.4) was incubated for 24 h at 37 °C and soni-
cated briefly [32]. Samples were prepared using conven-
tional methods for negative stain preparation [33]. Imaging
was at room temperature using a Morgagni 268 at 100 kV.
Images were acquired at 22 0009 with an Orius 2000 CCD
camera with a pixel size of 2.4 A.
Results
Mod5 directly binds to substrate and
nonsubstrate RNAs
In our in vitro assays, we worked with three tRNAs that
are predicted substrates for Mod5modification:
matTyrtRNA (mature tRNA with 50 leader, intron
and 30 trailer removed), preSertRNA (with 50 leader
and 30 trailer), and matSertRNA (with leader and
trailer sequences removed). We also used nonsubstrate
mature tRNAs (matLeutRNA), nonsubstrate pre-
tRNAs (preTyrtRNA, preLeutRNA, and pre-
AlatRNA), and nonsubstrate 5S rRNA (Table S1).
MatTyr, preSer, and matSertRNAs contain the
AAA36–38 sequence requirement for modification, while
the intron in the preTyrtRNA disrupts the AAA and
thus is not predicted to be modified by the enzyme at
A37. The matLeu, preLeu, matAla, and pre-
AlatRNA sequences do not contain the required
AAA at the anticodon loop, nor an A at position 37,
and are therefore predicted to be nonsubstrates for
isopentenylation (Table S1).
To confirm these predictions and the activity of the
isolated Mod5 enzyme, we performed isopentenyl trans-
ferase assays in the presence or absence of DMAPP sub-
strate and each RNA. The modification reaction was
followed by the digestion of the products with RNase
T1 (which cleaves on the 30 side of guanosine residues
leaving a 30GMP) and analysis of oligonucleotide frag-
ments on denaturing polyacrylamide gels. The transfer
of a dimethylallyl/isopentenyl group from DMAPP to
the RNA would result in a DMAPP-dependent shift of
the indicated RNase T1fragment containing the modi-
fied base (Fig. S1). As predicted, matTyr, matSer,
and pre-Ser tRNAs are modified at the oligo containing
the A37 position (Fig. 1A), while pre-Ala, pre-
TyrtRNA, preLeutRNA, and LeutRNA are
not modified (Fig. 1B; summarized in Table S1). These
data confirm the Mod5 substrate specificity in our
recombinant enzyme [1,3,5] and show that the enzyme is
capable of recognizing the folded substrates used for
in vitro binding assays. We note that we see an addi-
tional 7mer oligonucleotide that becomes modified in
the substrate mat-Ser and pre-Ser-tRNAs in the pres-
ence of Mod5 and DMAPP (Fig. 1A). A possible expla-
nation for this is that there is high sequence similarity in
this 7 nt fragment compared to the 10 nt A37-contain-
ing fragment (GAAUCC compared to AAAUCC in the
A37-containing fragment). Furthermore, although these
two sequences reside in different arms of the tRNA,
they are at similar relative positions within their respec-
tive arms (Fig. S3). The lack of a third A in the 7 nt
fragment as well as differences in positioning within the
tRNA might explain the differences in efficiency of
modification between the two, in which only ~ 30% of
the 7 nt fragment becomes modified under the condi-
tions used compared to nearly 100% in the A37-con-
taining 10 nt fragment.
Gel mobility shift assay (GMSA) analyses demon-
strate that Mod5 binds to both substrate and nonsub-
strate tRNAs and pretRNAs, as well as 5S RNA,
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within a similar range of protein concentrations
(Fig. 2A–H). At low concentrations of Mod5, in some
cases, there are discrete shifted RNA bands that likely
represent monomer, dimer, or higher complexes of
RNAs with Mod5, although there is some smearing of
signal in lanes consistent with either semistable com-
plexes or variably structured complexes under these
conditions. At higher concentrations of protein, these
give way for all RNAs to supershift at the gel inter-
face, suggesting a much larger or insoluble complex
(Fig. 2A–H, discussed below). We will address the
implications of these slow-migrating complexes below,
but at a minimum, these data suggest that Mod5
directly binds to RNAs regardless of whether the
RNA is a substrate for modification.
To investigate the relative binding strengths of these
RNAs with Mod5, we used a competition assay in which
Mod5 was bound to a constant concentration of 32Pla-
beled preTyrtRNA, in the presence of increasing
amounts of unlabeled competitor RNAs. We determined
apparent IC50 values for the nonsubstrate pre-
LeutRNA, preAlatRNA, and preTyrtRNA to
be similar (0.4, 1.0, and 0.8 lM, respectively, Fig. 3A, D,
and E.). We further determined the competitive strength
of two other nonsubstrates including a highly structured
nontRNA (5S rRNA, Fig. 3F) and LeutRNA
(Fig. 3C), and one other substrate RNA, TyrtRNA
(Fig. 3B). LeutRNA, TyrtRNA, and 5S-rRNA
sequences (IC50 values 3.5, 1.5, and 1.6 lM, respectively)
competed with similar strengths to other RNAs tested.
Substrates for A37 modificationA
B
Mat-Tyr
Mod5
DMAPP
*UAAAUCUU
*AAAUCCAU
-UG
AAAUCCAU
-UG
AAUCCUG
ACUACG
UAAAUCUU
CCAAG
G
10 nt (I6a)
10 nt (I6a)
10 nt 
10 nt 
7 nt (I6A?)
7 nt
6 nt
5 nt
4 nt
3 nt
*AAAUCCAU
-UG
ACUACG
AAUCCUG
ACUAG
10 nt (I6a)
10 nt 
7 nt (I6A?)
7 nt
6 nt
5 nt
4 nt
3 nt
5 nt 
4 nt 
3 nt 
G
+
–
+
+
Mat-Ser
+
–
+
+
Pre-Ser
+
–
+
+
Nonsubstrates for A37 modification
Pre-Ala
Mod5
DMAPP
UUCAAUCC
-CCG
UAAUUUA
UCACUAC
G
-
AAAUCG
CCAAG
AAAUCUUG
11 nt
9 nt 
15 nt 
6 nt
8 nt
5 nt
4 nt
3 nt
CAACCAUU-
AUUUU
AAAAUAUC-
UUG
AAUCUCU-
UAG
AUUCAAG
CAACCA
AAUCUCUU-
AG
AAUACUCA-
G
10 nt 
10 nt 
11 nt 
13 nt 
7 nt
7 nt
9 nt
6 nt
6 nt
4 nt 4 nt
3 nt
3 nt
5 nt 
4 nt 
3 nt 
+
–
+
+
Pre-Tyr
+
–
+
+
Pre-Leu
+
–
+
+
Mat-Leu
+
–
+
+
Fig. 1. Mod5 isopentenylation assays. (A)
Substrate or (B) nonsubstrate tRNA genes
were transcribed in the presence of 32P-
adenosine creating internally labeled
RNAs. RNAs were then incubated with
Mod5 in the presence or absence of
DMAPP. The samples were subsequently
digested with RNase T1 and fragments
separated with 20% denaturing PAGE.
Fragments containing the modifiable
adenosine in the absence of DMAPP are
indicated with an asterisk*. A shifted band
in the presence of DMAPP indicates the
presence of a modified adenosine
containing an isopentenyl group (See
Fig. S1).
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In general, these data are consistent with our previously
published in vivo data showing that Mod5 coimmuno-
precipitates with both substrate and nonsubstrate
tRNAs [22] and suggests that the capacity to serve as a
substrate for modification does not predict which RNAs
Mod5 can bind.
tRNA accelerates aggregation of Mod5
As noted above, at the higher Mod5:RNA ratios, the
majority of the RNA is bound in a complex with pro-
teins that remains near the well interface of the gel,
suggesting that the RNA is bound to a multimerized
or aggregated form of Mod5. This suggested that
aggregation of Mod5 is not prevented by its interac-
tion with RNA and possibly takes the form of amyloid
fibers as observed by others [29]. We thus examined
the physical form of these interactions further.
To compare the rates of aggregation, we measured
solution light scattering using absorbance at 405 nm as
a measure of Mod5 precipitation/aggregation over time
(Fig. 4A). The sample containing Mod5 without RNA
demonstrated a modest increase in A405, while the addi-
tion of substrates matTyrtRNA, preSertRNA, or
matSer-tRNA led to a threefold to eightfold increase
in A405 by 10 h compared to the Mod5only sample.
Similarly, addition of nonsubstrate preLeutRNA or
preTyrtRNA led to sixfold to sevenfold increase in
A405. In contrast, combining Mod5 with 5S-rRNA did
not lead to a significant change, notable given the
GMSA and competition results (Figs 2 and 3) showing
Mod5 binding to 5S rRNA. These results suggest that
tRNA-like binding accelerates the aggregation of Mod5,
but that the nature of the bound RNA is important.
Mod5 forms both punctate aggregates and
extended fibers in the presence or absence of
RNA
Mod5 was previously shown to form amyloid fibers
in vitro and aggregates in vivo under selective pressure
[11,29]. We tested whether RNA affects the ability of
Mod5 to form amyloid fibers by examining protein sam-
ples +/ RNA using fluorescence and electron micro-
scopy (EM). We also imaged fibers formed in the
presence of fluorescently labeled preSertRNA to test
whether the RNA itself was associated with the protein
aggregates. Consistent with our GMSAs (Fig. 2A–G),
we observe Mod5 fibers and punctate aggregates bound
to the fluorescent RNA (Fig. 4B). For both protein-
Well
Unbound
Pre-Leu
Pre-Ala Pre-Ser Mat-Ser 5S
Mat-Leu Pre-Tyr Mat-Tyr
Bound
Mod5A B C D
E F G H
Well
Unbound
Bound
Mod5
Well
Unbound
Bound
Mod5
Well
Unbound
Bound
Mod5
Well
Unbound
Bound
Mod5
Well
Unbound
Bound
Mod5
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Unbound
Bound
Mod5
Well
Unbound
Bound
Mod5
Fig. 2. Mod5 binds to substrate and
nonsubstrate RNAs. Phosphorimage of
representative nondenaturing gel
electrophoretograms of purified
recombinant Mod5 and 32P-labeled RNAs
(A) pre-Leu-tRNA, (B) mat-Leu-tRNA, (C)
pre-Tyr-tRNA, (D) mat-Tyr-tRNA, (E) pre-
Ala-tRNA, (F) h-pre-Ser-tRNA, and (G)mat-
Ser-tRNA (H) 5S-rRNA with decreasing
Mod5 concentrations (5.33, 1.78, 0.593,
0.198, 0.0658, 0.0219, 0.00732, 0.00244,
0.000813, and 0.00 lM. In (H), the lane
with 0.00244 lM Mod5 was omitted).
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only samples and those incubated with various RNAs,
we observed both punctate particulates and fibers using
EM (Fig. 4C–H) confirming previous observations [29].
The size of the punctate particulates as well as the pres-
ence of fibers suggested protein multimers. Individual
fibers had an approximate diameter of 5–10 nm and
were often seen in bundles with diameters as large as
50 nm. The resolution of this analysis precluded detec-
tion of quantitative differences in the dimensions of
individual fibers, while spectroscopic assays for changes
in the rate of fiber versus particle formation were
inconclusive (Fig. S4): thus, more detailed analysis of
differences with or without RNA awaits further investi-
gation.
Discussion
We herein demonstrated that Mod5 directly binds to
both substrate and nonsubstrate RNAs in vitro. This
is in agreement with our hypothesis that Mod5-tRNA
interactions play a role in the mechanism of tgm -silen-
cing, where Mod5 binds the nascent pretRNA
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Fig. 3. Effect of Mod5 binding to 32P-labeled pre-Tyr RNA in the presence of substrate and nonsubstrate RNAs. Phosphorimages of
representative (of three repetitions) nondenaturing gel electrophoretograms with indicated concentrations of unlabeled (A) pre-Leu-tRNA, (B)
mat-Tyr-tRNA, (C) mat-Leu-tRNA, (D) h-pre-Ala-tRNA, (E) pre-Tyr-tRNA, and (F) 5S-rRNA, with a graphic representation (to the left of each
phosphorimage) of concentration-dependent effect of Mod5 binding to 32P-labeled pre-Tyr-tRNA by unlabeled competitor RNAs. (G) A table
of IC50 values and 95% confidence intervals by RNA.
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transcripts as a prerequisite for subsequent interactions
that modify and remodel local chromatin structure.
This is consistent with our previous in vivo data show-
ing that Mod5 copurifies with the precursor and
mature forms of both substrate and nonsubstrate
tRNAs [22]. The ability of the enzyme to bind with
similar affinities to both substrate and nonsubstrate
pre-tRNAs suggests that although the presence of an
AAA at the A36–A38 position of the active site is pre-
dictive of modification activity [14], it is not a major
determinant of RNA-binding behavior of Mod5. The
observed differences in binding among tRNAs, pre-
tRNAs, and 5S-rRNA are relatively small, suggesting
substantial tolerance for variations in RNA structure,
as well as sequence, for binding to Mod5.
Interestingly, upon the addition of RNA to purified
Mod5, we observed a marked increase in light scattering
with all tRNAs and pre-tRNAs tested, but not 5S-
rRNA (Fig. 4A). These observations suggest that
tRNA-like molecules can stimulate Mod5 aggregation
whether or not they are substrates for isopentenylation
(Fig. 4A). The reason for the markedly different aggre-
gation behavior of 5S-rRNA, even though it binds to
Mod5 and can compete with tRNA binding, is currently
unclear, but could reflect a fundamentally different
structure in the ribonucleoprotein. This would not be
surprising, because the enzyme evolved specifically to fit
a tRNA structure into the active site [14] and the overall
effect on the structure of the complex could be quite dis-
tinct with a differently shaped RNA.
A second observation of interest comes from the effect
of RNAs on aggregation by Mod5. It was previously
shown that Mod5 is able to form amyloid-like aggregates
and that this aggregation can be selected in vivo by select-
ing against functional tRNA-modifying activity in the
cytoplasm with an antifungal agent, fluconazole [29].
However, we previously showed that the nuclear silencing
function of Mod5 is not ablated when aggregation is
selected by this stressor [11], suggesting that the nuclear
pool of Mod5 that is associated with RNA polymerase
III transcription complexes and pretRNAs was not sub-
ject to the aggregation behavior of the cytoplasmic pool.
Fig. 4. tRNAs increase Mod5-aggregation,
Mod5 forms amyloid fibers in the
presence of RNA, and the fibers bind
RNA. (A) Protein incubated with substrate
tRNAs (mat-Tyr-tRNA, pre-Ser-tRNA, mat-
Ser-tRNA) or nonsubstrate tRNAs (pre-Tyr-
tRNA, pre-Leu-tRNA) demonstrated a
~ fivefold to eightfold increase in
absorbance after 10 h compared to the
Mod5-only sample. Protein incubated with
5S-rRNA did not increase overall
absorbance. (B) Mod5 amyloid fibers
bound to a fluorescein-labeled Ser-tRNA.
(C–H) Electron micrographs of Mod5
amyloid fibers formed (from left to right) in
the (C) absence of RNA, or the presence
of (D) pre-Leu-tRNA, (E) mat-Leu-tRNA, (F)
pre-Tyr-tRNA, (G) mat-Tyr-tRNA, or (H) 5S-
rRNA. 22 0009 magnification.
1608 FEBS Letters 591 (2017) 1601–1610 ª 2017 Federation of European Biochemical Societies
Aggregation of Mod5 is affected by tRNA binding D. F. Read et al.
As aggregation of the purified enzyme is not prevented by
RNA binding, and if anything is enhanced by it, we infer
that the immunity of the nuclear function to fluconazole-
selected aggregation might be due to other interactions of
Mod5 in the nucleus. We propose an alternative model in
which the RNA-bound form of Mod5 could be the ‘ac-
tive’ conformation of the nuclear enzyme, with the
enhanced aggregation a necessary part of its nuclear func-
tion. Under this model, tgm silencing is facilitated by the
multimerization of Mod5 which might extend the Mod5-
particle to neighboring gene promoters to either attract
chromatin modifiers or block access of the transcription
machinery to the DNA.
Suzuki and colleagues originally reported that aggre-
gated Mod5 in the cytoplasm conveys resistance to cer-
tain fungicides [29], which might be consistent with the
property having evolved in fungi to provide a reserve
population of yeast that are resistant to antifungal
attack. Interestingly, the human orthologue, TRIT1, has
retained both the cytoplasmic and nuclear functions of
Mod5 [22], and we recently demonstrated that it retains
the amyloid fibril formation potential of Mod5 [34]. It is
not clear why fibril formation would have been retained
in an organism as distant from fungi as humans if cyto-
plasmic aggregation were the selective pressure,
although it is possible that this method of removing
Mod5 might regulate cholesterol biosynthesis or protein
prenylation by modulating the availability of substrates.
We suggest an alternative hypothesis, that the fibril for-
mation is a positive attribute in tgm silencing that has
been conserved for that reason. The observation that
apparent RNA-mediated silencing has been observed
near pol III transcription units in human cells [28] would
be consistent with such a conservation of function.
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